BVP Bioscience Vct

0.00

0.00 (0.00%)

- - Closed

Delayed by 15 minutes

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Bioscience Vct	LSE:BVP	London	Ordinary Share	GB0031256109	ORD 50P

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	0.00	0.00%							0.00	-

Industry Sector	Turnover	Profit	EPS - Basic	PE Ratio	Market Cap
	0	0		N/A	0

Hygea VCT plc Scancell to present at Biotech Capital

24/02/2016 10:42am

RNS Non-Regulatory

TIDMHYG

Hygea VCT plc

24 February 2016

For immediate release 24 February 2016

Hygea vct plc

Scancell plc to present at Biotech Capital in London on 3rd March 2016

The Board of Hygea vct plc announces that Hygea's largest investment by value, Scancell plc (www.scancell.co.uk), is presenting at the Biotech Capital Conference being held in London on 3rd March 2016. Attendance is free, with registration via www.biotech-capital.com/conferences - a recording of the event will be posted on the website. An article Immunotherapy: a turning point in cancer treatment by Vadim Alexandre can be found on page 8 of the AIM Journal (http://www.hubinvest.com/AIMPDFFebruary2016_77.pdf).

Enquiries: Charles Breese, director on 01280 703482

This information is provided by RNS

The company news service from the London Stock Exchange

END

NRAUSSRRNAAUUAR

(END) Dow Jones Newswires

February 24, 2016 05:42 ET (10:42 GMT)